Treatment of thrombotic microangiopathies with plasma exchange

Hematology

Volumn 12, Issue 1, 2007, Pages 63-67

  Basic Jukic, Nikolina ^a   Kes, Petar ^a   Bubic Filipi, Ljubica ^a   Brunetta, Bruna ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Fresh frozen plasma; Plasma exchange; Renal failure; Thrombotic microangiopathy

Indexed keywords

CYCLOSPORIN A; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; VINCRISTINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CROATIA; DISEASE COURSE; FATALITY; FEMALE; FEVER; FOLLOW UP; HEMOLYSIS; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; METASTASIS; NEUROLOGIC DISEASE; PATIENT MONITORING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PURPURA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANAPHYLAXIS; ANEMIA, HEMOLYTIC; CATHETERS, INDWELLING; COMBINED MODALITY THERAPY; CONFUSION; DISEASE PROGRESSION; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HEMORRHAGE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; SYNDROME; THROMBOSIS;

EID: 33947154767     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600938687     Document Type: Article

References (20)

1. Tsai, HM (2003) Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol, 14, pp. 1072-1081.
2. Tsai, HM and Lian, ECY (1998) Antibodies to von-Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med, 339, pp. 1585-1594.
3. von Baeyer, H. (2002) Plasmapheresis in thrombotic microangiopathy-associated syndromes: Review of outcome data derived from clinical trials and open studies. Ther Apher, 6, pp. 320-328.
4. Kaplan, AA (1990) A simple and accurate method for prescribing plasma exchange. Trans Am Soc Artif Intern Organs, 36, pp. 597-599.
5. Rock, GA, Shumak, KH and Buskard, NA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med, 325, pp. 393-397.
6. Rock, G., Shumak, K. and Kelton, J. (1992) Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange. Transfusion, 32, pp. 710-714.
7. Bell, WR, Braine, HG and Ness, PM (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Clinical experience in 108 patients. N Engl J Med, 325, pp. 398-403.
8. George, JN (2000) How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood, 96, pp. 1223-1229.
9. Hayward, CPM, Sutton, DMC and Carter Jr, WH (1994) Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med, 154, pp. 982-987.
10. Shumak, KH, Rock, GA and Nair, RC (1995) The Canadian Apheresis Group. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med, 122, pp. 572-596.
11. Vesely, SK, George, JN and Raskob, GE (1999) Longterm clinical outcomes of thrombotic thrombocytopenic purpura-hemoytic-uremic syndrome (TTP-HUS) among different patients groups. Blood, 94, p. 15a.
12. Remuzzi, G. and Ruggenenti, P. (1995) The hemolytic uremic syndrome. Kidney Int, 47, pp. 2-19.
13. Ruggegenti, P. and Remuzzi, G. (1996) The patophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol, 56, pp. 191-207.
14. Kincaid-Smith, P. (1975) Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int, 7, pp. 242-253.
15. Hollenbeck, M., Kutkuhn, B., Aul, C., Lecshke, M., Willers, R. and Grabensee, B. (1998) Haemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults: Clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant, 13, pp. 76-81.
16. Kes, P. (1998) Efficacy of therapeutic plasma exchange in specific renal disease. Acta Med Croatica, 52, pp. 49-63.
17. Basic-Jukic, N., Kes, P. and Puretic, Z. (2005) Complications of plasma exchange. Experience with 4857 treatments. Ther Apher Dial, 9, pp. 391-395.
18. Rizvi, MA, Vesely, SK and George, JN (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion, 40, pp. 896-901.
19. Bueno Jr, D., Sevigny, J. and Kaplan, AA (1999) Extracorporeal treatment of thrombotic microangiopathy: A ten year experience. Ther Apher, 3, pp. 294-297.
20. Kelton, JG (2002) Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Will recent insight into pathogenesis transplate into better treatment?. Transfusion, 42, pp. 388-392.